Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 11, 2007, Pages 1331-1334

  Pradalier, A ^a   Neukirch, C ^b   Dreyfus, I ^c   Devillier, P ^d  

^a HÔPITAL LOUIS MOURIER   (France)

^b BICHAT HOSPITAL   (France)

^c Schering Plough   (France)

^d FOCH HOSPITAL   (France)

Author keywords

Allergic rhinitis; Desloratadine; GA2LEN; Quality of life

Indexed keywords

DESLORATADINE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARALLEL DESIGN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOM; UNSPECIFIED SIDE EFFECT;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL;

EID: 35148833541     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01374.x     Document Type: Article

References (15)

1. Global Allergy and Asthma European Network (GA2LEN). Allergy and asthma: Global Disease. Available at: http://www.ga2len.net/index.cfm?action= viewPublicPage&pageID=1678 (accessed December 14, 2006).
2. Beasley R The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998 351 : 1225 1232.
3. Burney P, Chinn S, Jarvis D, Luczynska C, Lai E. On behalf of the European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996 9 : 687 695.
4. Asher MI, Montefort S, Björkstön B, Lai CKW, Strachan DP, Weiland SK, Williams H. The ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006 368 : 733 743.
5. Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics 2004 22 : 345 361.
6. Fokkens WJ. Who should treat patients with seasonal allergic rhinitis Allergy 2002 57 : 469 471.
7. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma: a population-based study of young adults. Am J Respir Crit Care Med 2000 162 : 1391 1396.
8. European Academy of Allergology and Clinical Immunology. The impact of allergic rhinitis on quality of life and other airway diseases. Summary of a European conference. Allergy 1998 53 (Suppl. 41 7 31.
9. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996 98 : 843 845.
10. Meltzer EO, Jalowayski AA, Vogt K, Iezzoni D, Harris AG. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial. Ann Allergy Asthma Immunol 2006 96 : 363 368.
11. Berger WE, Schenkel EJ, Mansfield LE. Desloratadine Study Group. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Ann Allergy Asthma Immunol 2002 89 : 485 491.
12. Nayak AS, Schenkel E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy 2001 56 : 1077 1080.
13. Canonica GW, Tarantini F, Compalati E, Penagos M. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Allergy 2007 62 : 359 366.
14. Heithoff K, Meltzer EO, Mellars L, Salmun M. Desloratadine improves quality of life in patients with seasonal allergic rhinitis. J Allergy Clin Immunol 2000 104 (Suppl. S383 abstract 1121.
15. Satish U, Streufert S, Dewan M, Voort SV. Improvements in simulated real-world relevant performance for patients with seasonal allergic rhinitis: impact of desloratadine. Allergy 2004 59 : 415 420.